Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock
Status:
Withdrawn
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to perform a pilot study to assess the potential use of
Bevacizumab (a vascular endothelial growth factor (VEGF) inhibitor) in sepsis.